Both in Pharmaceuticals
Jaguar Health vs Valion Bio
Over the past year JAGX returned −78.8% and VBIO returned −77.1%; their daily moves had a correlation of -0.08.
JAGX −78.8% VBIO −77.1%Growth of $1, one year, split-adjusted
| Metric | JAGX | VBIO |
|---|---|---|
| Price | $0.4988 | $0.5171 |
| Market cap | $1.2M | $1.1M |
| Today | −10.53% | −2.60% |
| 1 month | −82.2% | −78.3% |
| 6 months | −97.6% | — |
| Year to date | −99.8% | — |
| 1 year | −99.9% | — |
| Revenue growth (YoY) | −58.9% | — |
| Gross margin | 15.8% | — |
| Net margin | −1036.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.0× | — |
| Net cash | -$11.8M | -$5.3M |
| Dividend yield | — | — |
| Volatility (60d) | 1,076.0% | — |
| Short % of float | 2.0% | 9.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).